Works matching IS 10870156 AND DT 2014 AND VI 32 AND IP 5


Results: 37
    1
    2
    3

    Pfizer matchmakers in Asia.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 406, doi. 10.1038/nbt0514-406a
    By:
    • Elvidge, Suzanne
    Publication type:
    Article
    4
    5
    6
    7
    8

    Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 479, doi. 10.1038/nbt.2892
    By:
    • Lohr, Jens G;
    • Adalsteinsson, Viktor A;
    • Cibulskis, Kristian;
    • Choudhury, Atish D;
    • Rosenberg, Mara;
    • Cruz-Gordillo, Peter;
    • Francis, Joshua M;
    • Zhang, Cheng-Zhong;
    • Shalek, Alex K;
    • Satija, Rahul;
    • Trombetta, John J;
    • Lu, Diana;
    • Tallapragada, Naren;
    • Tahirova, Narmin;
    • Kim, Sora;
    • Blumenstiel, Brendan;
    • Sougnez, Carrie;
    • Lowe, Alarice;
    • Wong, Bang;
    • Auclair, Daniel
    Publication type:
    Article
    9
    10
    11
    12
    13

    Going it alone.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 411, doi. 10.1038/nbt.2896
    Publication type:
    Article
    14
    15
    16
    17

    Oral immunotherapy approved.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 405, doi. 10.1038/nbt0514-405c
    By:
    • Tse, Man Tsuey
    Publication type:
    Article
    18
    19
    20

    Simply better glycoproteins.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 443, doi. 10.1038/nbt.2893
    By:
    • Lepenies, Bernd;
    • Seeberger, Peter H
    Publication type:
    Article
    21
    22
    23

    Research Highlights.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 446, doi. 10.1038/nbt.2900
    Publication type:
    Article
    24
    25

    People.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 498, doi. 10.1038/nbt.2911
    Publication type:
    Article
    26

    Rarefied drug pricing.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 398, doi. 10.1038/nbt.2912
    Publication type:
    Article
    27
    28
    29
    30
    31

    Illumina incubates innovators.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 405, doi. 10.1038/nbt0514-405b
    By:
    • Proffitt, Allison
    Publication type:
    Article
    32

    Venter to sequence longevity.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 406, doi. 10.1038/nbt0514-406b
    By:
    • Brazil, Rachel
    Publication type:
    Article
    33
    34

    Drug pipeline: 1Q14.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 409, doi. 10.1038/nbt.2902
    By:
    • DeFrancesco, Laura
    Publication type:
    Article
    35

    Tumor signatures in the blood.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 441, doi. 10.1038/nbt.2897
    By:
    • Speicher, Michael R;
    • Pantel, Klaus
    Publication type:
    Article
    36

    Surveying the best in translation.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 5, p. 415, doi. 10.1038/nbt.2887
    By:
    • Grunseth, Matthew;
    • Chen, Calvin;
    • Kelly, Ryan;
    • Cook, Sangeeta Bardhan;
    • Megaw, George;
    • Couture, Larry
    Publication type:
    Article
    37